Furthermore, the reduction in SMAD2/3 phosphorylation following treatment with HE and OE suggests that these compounds may exert their antifibrotic effects by interfering with the TGF-β/SMAD signaling pathway, thereby preventing the transcriptional activation of genes responsible for fibrotic matrix accumulation. Here, TGFB1 is linked to hereditary elliptocytosis.